Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study
- 6 April 2025
- journal article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 23 (3) , 102342
Abstract
No abstract availableKeywords
Funding Information
- Santé
This publication has 19 references indexed in Scilit:
- Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian CentersEuropean Urology Focus, 2022
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateEuropean Urology, 2022
- Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving SunitinibJAMA Oncology, 2019
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumEuropean Urology, 2014
- The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experimentsStatistics in Medicine, 2013
- The performance of different propensity score methods for estimating marginal hazard ratiosStatistics in Medicine, 2012
- The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studiesStatistics in Medicine, 2010
- Cytoreductive Nephrectomy for Kidney Cancer With Sarcomatoid Histology—Is Up-Front Resection Indicated and, if Not, is it Avoidable?Journal of Urology, 2009
- Performance status and cytoreductive nephrectomyCancer, 2008
- A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression modelComputer Methods and Programs in Biomedicine, 2007